| 0 |
HEADACHE |
7801 |
| 1 |
OFF LABEL USE |
7493 |
| 2 |
FATIGUE |
5849 |
| 3 |
SINUSITIS |
4681 |
| 4 |
NAUSEA |
4631 |
| 5 |
PYREXIA |
4435 |
| 6 |
DRUG INEFFECTIVE |
4164 |
| 7 |
PNEUMONIA |
3797 |
| 8 |
DYSPNOEA |
3785 |
| 9 |
MALAISE |
3350 |
| 10 |
PAIN |
3319 |
| 11 |
NO ADVERSE EVENT |
3199 |
| 12 |
PRURITUS |
3110 |
| 13 |
COVID-19 |
2978 |
| 14 |
CHILLS |
2913 |
| 15 |
INFECTION |
2813 |
| 16 |
VOMITING |
2746 |
| 17 |
PRODUCT DOSE OMISSION ISSUE |
2670 |
| 18 |
RASH |
2669 |
| 19 |
DEATH |
2564 |
| 20 |
DIARRHOEA |
2561 |
| 21 |
INFUSION RELATED REACTION |
2437 |
| 22 |
COUGH |
2338 |
| 23 |
URTICARIA |
2293 |
| 24 |
DIZZINESS |
2194 |
| 25 |
URINARY TRACT INFECTION |
2140 |
| 26 |
FALL |
2121 |
| 27 |
NASOPHARYNGITIS |
2103 |
| 28 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2061 |
| 29 |
ASTHENIA |
2053 |
| 30 |
ARTHRALGIA |
1957 |
| 31 |
INFUSION SITE PAIN |
1939 |
| 32 |
ILLNESS |
1887 |
| 33 |
WEIGHT DECREASED |
1851 |
| 34 |
INFUSION SITE ERYTHEMA |
1825 |
| 35 |
INFUSION SITE SWELLING |
1818 |
| 36 |
BRONCHITIS |
1817 |
| 37 |
BLOOD PRESSURE INCREASED |
1815 |
| 38 |
PRODUCT USE IN UNAPPROVED INDICATION |
1690 |
| 39 |
BACK PAIN |
1669 |
| 40 |
CONDITION AGGRAVATED |
1421 |
| 41 |
UPPER RESPIRATORY TRACT INFECTION |
1419 |
| 42 |
MIGRAINE |
1416 |
| 43 |
PAIN IN EXTREMITY |
1413 |
| 44 |
INFLUENZA |
1407 |
| 45 |
ERYTHEMA |
1364 |
| 46 |
HYPERTENSION |
1307 |
| 47 |
INSURANCE ISSUE |
1283 |
| 48 |
HYPERSENSITIVITY |
1282 |
| 49 |
WEIGHT INCREASED |
1275 |
| 50 |
ABDOMINAL PAIN |
1213 |
| 51 |
PRODUCT USE ISSUE |
1203 |
| 52 |
TACHYCARDIA |
1174 |
| 53 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1147 |
| 54 |
PERIPHERAL SWELLING |
1112 |
| 55 |
FEELING ABNORMAL |
1110 |
| 56 |
DECREASED APPETITE |
1108 |
| 57 |
SEPSIS |
1101 |
| 58 |
INFUSION SITE PRURITUS |
1094 |
| 59 |
CHEST PAIN |
1076 |
| 60 |
ASTHMA |
1071 |
| 61 |
EAR INFECTION |
1042 |
| 62 |
HYPOTENSION |
1022 |
| 63 |
SWELLING |
1013 |
| 64 |
CHEST DISCOMFORT |
977 |
| 65 |
MYALGIA |
968 |
| 66 |
INJECTION SITE ERYTHEMA |
946 |
| 67 |
SOMNOLENCE |
943 |
| 68 |
INJECTION SITE PAIN |
925 |
| 69 |
RESPIRATORY TRACT INFECTION |
914 |
| 70 |
INFLUENZA LIKE ILLNESS |
895 |
| 71 |
DRUG HYPERSENSITIVITY |
887 |
| 72 |
TREMOR |
884 |
| 73 |
MENINGITIS ASEPTIC |
867 |
| 74 |
CONTUSION |
854 |
| 75 |
THERAPY INTERRUPTED |
829 |
| 76 |
INJECTION SITE SWELLING |
821 |
| 77 |
INFUSION SITE EXTRAVASATION |
817 |
| 78 |
ANXIETY |
816 |
| 79 |
ABDOMINAL PAIN UPPER |
807 |
| 80 |
HOSPITALISATION |
788 |
| 81 |
VIRAL INFECTION |
787 |
| 82 |
ANAPHYLACTIC REACTION |
781 |
| 83 |
INCORRECT DOSE ADMINISTERED |
772 |
| 84 |
INSOMNIA |
758 |
| 85 |
MUSCLE SPASMS |
750 |
| 86 |
MUSCULAR WEAKNESS |
750 |
| 87 |
OROPHARYNGEAL PAIN |
741 |
| 88 |
INTENTIONAL PRODUCT USE ISSUE |
734 |
| 89 |
ANAEMIA |
720 |
| 90 |
GASTROINTESTINAL DISORDER |
719 |
| 91 |
INFUSION SITE BRUISING |
712 |
| 92 |
ABDOMINAL DISTENSION |
710 |
| 93 |
OXYGEN SATURATION DECREASED |
706 |
| 94 |
INFUSION SITE HAEMORRHAGE |
703 |
| 95 |
DRUG INTOLERANCE |
693 |
| 96 |
HEART RATE INCREASED |
683 |
| 97 |
ARTHRITIS |
672 |
| 98 |
HYPOAESTHESIA |
663 |
| 99 |
PULMONARY EMBOLISM |
663 |
| 100 |
NEUTROPENIA |
654 |
| 101 |
GAIT DISTURBANCE |
646 |
| 102 |
ILL-DEFINED DISORDER |
646 |
| 103 |
PARAESTHESIA |
643 |
| 104 |
LOSS OF CONSCIOUSNESS |
638 |
| 105 |
FLUSHING |
633 |
| 106 |
MUSCULOSKELETAL STIFFNESS |
632 |
| 107 |
INCORRECT DRUG ADMINISTRATION RATE |
626 |
| 108 |
DEHYDRATION |
625 |
| 109 |
THERAPY NON-RESPONDER |
619 |
| 110 |
THROMBOSIS |
613 |
| 111 |
ABDOMINAL DISCOMFORT |
612 |
| 112 |
THROMBOCYTOPENIA |
586 |
| 113 |
HYPERHIDROSIS |
583 |
| 114 |
JOINT SWELLING |
578 |
| 115 |
PLATELET COUNT DECREASED |
569 |
| 116 |
GASTROENTERITIS VIRAL |
567 |
| 117 |
BLOOD PRESSURE DECREASED |
564 |
| 118 |
WHEEZING |
563 |
| 119 |
MATERNAL EXPOSURE DURING PREGNANCY |
562 |
| 120 |
SEASONAL ALLERGY |
560 |
| 121 |
SEIZURE |
556 |
| 122 |
SYNCOPE |
552 |
| 123 |
CELLULITIS |
548 |
| 124 |
POOR VENOUS ACCESS |
546 |
| 125 |
CEREBROVASCULAR ACCIDENT |
542 |
| 126 |
INJECTION SITE PRURITUS |
534 |
| 127 |
CONSTIPATION |
525 |
| 128 |
FOETAL EXPOSURE DURING PREGNANCY |
523 |
| 129 |
VISION BLURRED |
516 |
| 130 |
HERPES ZOSTER |
514 |
| 131 |
MULTIPLE ALLERGIES |
508 |
| 132 |
NECK PAIN |
507 |
| 133 |
LOWER RESPIRATORY TRACT INFECTION |
504 |
| 134 |
PRODUCTIVE COUGH |
502 |
| 135 |
HAEMOGLOBIN DECREASED |
483 |
| 136 |
NEUROPATHY PERIPHERAL |
476 |
| 137 |
RESPIRATORY FAILURE |
475 |
| 138 |
LUNG DISORDER |
464 |
| 139 |
NEOPLASM MALIGNANT |
454 |
| 140 |
SEPTIC SHOCK |
454 |
| 141 |
GENERAL PHYSICAL HEALTH DETERIORATION |
452 |
| 142 |
FUNGAL INFECTION |
451 |
| 143 |
STAPHYLOCOCCAL INFECTION |
447 |
| 144 |
INFUSION SITE DISCHARGE |
446 |
| 145 |
BLOOD IMMUNOGLOBULIN G DECREASED |
444 |
| 146 |
CYSTITIS |
442 |
| 147 |
EXPOSURE DURING PREGNANCY |
441 |
| 148 |
RENAL FAILURE |
437 |
| 149 |
TREATMENT FAILURE |
434 |
| 150 |
INFUSION SITE MASS |
427 |
| 151 |
CONFUSIONAL STATE |
425 |
| 152 |
DEPRESSION |
423 |
| 153 |
PHOTOPHOBIA |
423 |
| 154 |
SINUS DISORDER |
421 |
| 155 |
BODY TEMPERATURE INCREASED |
419 |
| 156 |
HYPOXIA |
417 |
| 157 |
RHEUMATOID ARTHRITIS |
416 |
| 158 |
DEEP VEIN THROMBOSIS |
412 |
| 159 |
MEMORY IMPAIRMENT |
409 |
| 160 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
408 |
| 161 |
ATRIAL FIBRILLATION |
403 |
| 162 |
OEDEMA PERIPHERAL |
402 |
| 163 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
402 |
| 164 |
NASAL CONGESTION |
401 |
| 165 |
PALPITATIONS |
399 |
| 166 |
ACUTE KIDNEY INJURY |
397 |
| 167 |
STRESS |
397 |
| 168 |
RHINORRHOEA |
396 |
| 169 |
RASH PRURITIC |
395 |
| 170 |
ALOPECIA |
392 |
| 171 |
UNEVALUABLE EVENT |
392 |
| 172 |
EYE PAIN |
391 |
| 173 |
NEPHROLITHIASIS |
391 |
| 174 |
HAEMOLYSIS |
390 |
| 175 |
CARDIAC DISORDER |
388 |
| 176 |
ARTHROPATHY |
387 |
| 177 |
KIDNEY INFECTION |
387 |
| 178 |
MYOCARDIAL INFARCTION |
385 |
| 179 |
DYSPHAGIA |
382 |
| 180 |
ADVERSE DRUG REACTION |
380 |
| 181 |
DERMATITIS CONTACT |
380 |
| 182 |
WHITE BLOOD CELL COUNT DECREASED |
380 |
| 183 |
LYMPHADENOPATHY |
374 |
| 184 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
372 |
| 185 |
PANCYTOPENIA |
370 |
| 186 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
367 |
| 187 |
CATARACT |
366 |
| 188 |
DEVICE ISSUE |
364 |
| 189 |
INFUSION SITE REACTION |
362 |
| 190 |
LOCALISED INFECTION |
362 |
| 191 |
HAEMORRHAGE |
361 |
| 192 |
MOBILITY DECREASED |
361 |
| 193 |
SWELLING FACE |
355 |
| 194 |
OEDEMA |
353 |
| 195 |
HAEMOLYTIC ANAEMIA |
350 |
| 196 |
PLEURAL EFFUSION |
346 |
| 197 |
RECALLED PRODUCT ADMINISTERED |
346 |
| 198 |
NEEDLE ISSUE |
344 |
| 199 |
VISUAL IMPAIRMENT |
344 |
| 200 |
BURNING SENSATION |
342 |
| 201 |
PRODUCT DISTRIBUTION ISSUE |
338 |
| 202 |
EPISTAXIS |
337 |
| 203 |
TINNITUS |
337 |
| 204 |
ECZEMA |
334 |
| 205 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
334 |
| 206 |
DIPLOPIA |
333 |
| 207 |
HEAD DISCOMFORT |
332 |
| 208 |
COMA |
330 |
| 209 |
HEPATIC ENZYME INCREASED |
326 |
| 210 |
RENAL IMPAIRMENT |
324 |
| 211 |
BLISTER |
322 |
| 212 |
PSORIASIS |
318 |
| 213 |
FEELING HOT |
316 |
| 214 |
LEUKOPENIA |
314 |
| 215 |
LIMB INJURY |
313 |
| 216 |
BLINDNESS |
311 |
| 217 |
GENERALISED OEDEMA |
311 |
| 218 |
GASTROOESOPHAGEAL REFLUX DISEASE |
309 |
| 219 |
BACTERIAL INFECTION |
308 |
| 220 |
INJECTION SITE BRUISING |
308 |
| 221 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
308 |
| 222 |
DISCOMFORT |
307 |
| 223 |
FEELING COLD |
306 |
| 224 |
HYPOKALAEMIA |
306 |
| 225 |
RESPIRATORY DISTRESS |
305 |
| 226 |
LETHARGY |
304 |
| 227 |
HAEMATURIA |
303 |
| 228 |
PRESYNCOPE |
303 |
| 229 |
BALANCE DISORDER |
302 |
| 230 |
DRUG INTERACTION |
300 |
| 231 |
DISEASE PROGRESSION |
299 |
| 232 |
SKIN INFECTION |
299 |
| 233 |
JOINT INJURY |
297 |
| 234 |
TACHYPNOEA |
297 |
| 235 |
INJECTION SITE MASS |
294 |
| 236 |
DYSPHONIA |
292 |
| 237 |
INFLAMMATION |
292 |
| 238 |
PRODUCT QUALITY ISSUE |
292 |
| 239 |
THROAT TIGHTNESS |
290 |
| 240 |
ASCITES |
289 |
| 241 |
PRODUCT STORAGE ERROR |
289 |
| 242 |
ADRENAL INSUFFICIENCY |
288 |
| 243 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
287 |
| 244 |
INFUSION SITE NODULE |
286 |
| 245 |
INFUSION SITE RASH |
284 |
| 246 |
CYTOMEGALOVIRUS INFECTION |
283 |
| 247 |
RASH ERYTHEMATOUS |
283 |
| 248 |
INFUSION SITE URTICARIA |
279 |
| 249 |
LIMB DISCOMFORT |
279 |
| 250 |
LIP SWELLING |
278 |
| 251 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
278 |
| 252 |
DEVICE INFUSION ISSUE |
277 |
| 253 |
THERAPY CESSATION |
276 |
| 254 |
MYASTHENIA GRAVIS |
275 |
| 255 |
IMMUNODEFICIENCY |
274 |
| 256 |
PHARYNGITIS STREPTOCOCCAL |
273 |
| 257 |
THROAT IRRITATION |
269 |
| 258 |
DIABETES MELLITUS |
268 |
| 259 |
CARDIO-RESPIRATORY ARREST |
267 |
| 260 |
OCULAR DISCOMFORT |
266 |
| 261 |
RESPIRATORY DISORDER |
266 |
| 262 |
VERTIGO |
266 |
| 263 |
CANDIDA INFECTION |
265 |
| 264 |
ALTERED STATE OF CONSCIOUSNESS |
264 |
| 265 |
RENAL DISORDER |
261 |
| 266 |
HAEMATEMESIS |
260 |
| 267 |
TOOTH INFECTION |
259 |
| 268 |
SKIN EXFOLIATION |
250 |
| 269 |
IMMUNOGLOBULINS DECREASED |
249 |
| 270 |
INJECTION SITE REACTION |
246 |
| 271 |
ROAD TRAFFIC ACCIDENT |
244 |
| 272 |
COVID-19 PNEUMONIA |
243 |
| 273 |
SYRINGE ISSUE |
243 |
| 274 |
EYE INFECTION |
241 |
| 275 |
HAEMORRHAGIC STROKE |
241 |
| 276 |
PALLOR |
239 |
| 277 |
INFUSION SITE WARMTH |
238 |
| 278 |
INJECTION SITE HAEMORRHAGE |
238 |
| 279 |
WEIGHT FLUCTUATION |
238 |
| 280 |
PRODUCT AVAILABILITY ISSUE |
236 |
| 281 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
236 |
| 282 |
C-REACTIVE PROTEIN INCREASED |
235 |
| 283 |
POLYARTHRITIS |
235 |
| 284 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
233 |
| 285 |
DIVERTICULITIS |
231 |
| 286 |
UNDERDOSE |
231 |
| 287 |
TRANSIENT ISCHAEMIC ATTACK |
225 |
| 288 |
CARDIAC ARREST |
224 |
| 289 |
CLOSTRIDIUM DIFFICILE INFECTION |
224 |
| 290 |
FLUID RETENTION |
224 |
| 291 |
BLOOD PRESSURE ABNORMAL |
223 |
| 292 |
BONE PAIN |
223 |
| 293 |
MENINGITIS |
222 |
| 294 |
PRODUCT DOSE OMISSION IN ERROR |
222 |
| 295 |
INFUSION SITE INDURATION |
221 |
| 296 |
PREMATURE BABY |
221 |
| 297 |
BRAIN FOG |
219 |
| 298 |
HEAD INJURY |
216 |
| 299 |
INFUSION SITE DISCOMFORT |
214 |
| 300 |
OBESITY |
214 |
| 301 |
AMAUROSIS FUGAX |
213 |
| 302 |
FEBRILE NEUTROPENIA |
212 |
| 303 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
211 |
| 304 |
ANGIOEDEMA |
210 |
| 305 |
AUTOIMMUNE DISORDER |
210 |
| 306 |
FIBROMYALGIA |
210 |
| 307 |
BLOOD CREATININE INCREASED |
207 |
| 308 |
INABILITY TO AFFORD MEDICATION |
206 |
| 309 |
PSEUDOMONAS INFECTION |
204 |
| 310 |
THERAPY CHANGE |
204 |
| 311 |
MUSCULOSKELETAL PAIN |
203 |
| 312 |
SWOLLEN TONGUE |
203 |
| 313 |
URINARY TRACT DISORDER |
203 |
| 314 |
HYPOGAMMAGLOBULINAEMIA |
202 |
| 315 |
CARDIAC FAILURE |
201 |
| 316 |
SLEEP DISORDER |
201 |
| 317 |
DYSPEPSIA |
200 |
| 318 |
HEART RATE DECREASED |
200 |
| 319 |
NEURALGIA |
199 |
| 320 |
OSTEOPOROSIS |
198 |
| 321 |
DRY MOUTH |
196 |
| 322 |
SURGERY |
196 |
| 323 |
TREATMENT NONCOMPLIANCE |
196 |
| 324 |
BRONCHIECTASIS |
195 |
| 325 |
GASTROINTESTINAL INFECTION |
195 |
| 326 |
COLITIS |
194 |
| 327 |
RASH MACULAR |
194 |
| 328 |
ABORTION SPONTANEOUS |
193 |
| 329 |
INTERSTITIAL LUNG DISEASE |
192 |
| 330 |
SKIN LACERATION |
192 |
| 331 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
190 |
| 332 |
POST PROCEDURAL COMPLICATION |
188 |
| 333 |
RESPIRATORY RATE INCREASED |
188 |
| 334 |
GASTROINTESTINAL HAEMORRHAGE |
187 |
| 335 |
CARDIAC FAILURE CONGESTIVE |
186 |
| 336 |
INFUSION SITE IRRITATION |
185 |
| 337 |
SKIN DISCOLOURATION |
185 |
| 338 |
HYPOCALCAEMIA |
184 |
| 339 |
EAR PAIN |
183 |
| 340 |
SPEECH DISORDER |
183 |
| 341 |
CONTRAINDICATED PRODUCT ADMINISTERED |
182 |
| 342 |
DRY SKIN |
182 |
| 343 |
SCAR |
182 |
| 344 |
SYNOVITIS |
182 |
| 345 |
BLOOD GLUCOSE INCREASED |
181 |
| 346 |
BRADYCARDIA |
181 |
| 347 |
PNEUMONIA ASPIRATION |
181 |
| 348 |
SINUS CONGESTION |
181 |
| 349 |
PHARYNGITIS |
180 |
| 350 |
PULMONARY FIBROSIS |
180 |
| 351 |
URINE OUTPUT DECREASED |
180 |
| 352 |
FOOT FRACTURE |
179 |
| 353 |
PNEUMONIA BACTERIAL |
179 |
| 354 |
PREGNANCY |
178 |
| 355 |
WOUND |
177 |
| 356 |
LUNG INFECTION |
175 |
| 357 |
PRODUCT SUPPLY ISSUE |
175 |
| 358 |
HOT FLUSH |
174 |
| 359 |
PRODUCT USE COMPLAINT |
173 |
| 360 |
PULMONARY OEDEMA |
172 |
| 361 |
WHITE BLOOD CELL COUNT INCREASED |
172 |
| 362 |
NODULE |
171 |
| 363 |
HIP FRACTURE |
170 |
| 364 |
HYPERSOMNIA |
170 |
| 365 |
CONJUNCTIVITIS |
169 |
| 366 |
LIVER DISORDER |
168 |
| 367 |
TENDERNESS |
168 |
| 368 |
GAIT INABILITY |
165 |
| 369 |
MYELOSUPPRESSION |
165 |
| 370 |
ASPARTATE AMINOTRANSFERASE INCREASED |
163 |
| 371 |
CHRONIC SINUSITIS |
162 |
| 372 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
162 |
| 373 |
LIQUID PRODUCT PHYSICAL ISSUE |
162 |
| 374 |
AGITATION |
161 |
| 375 |
CYANOSIS |
161 |
| 376 |
ANAPHYLACTIC SHOCK |
160 |
| 377 |
PANCREATITIS |
160 |
| 378 |
ALANINE AMINOTRANSFERASE INCREASED |
159 |
| 379 |
LYMPHOMA |
159 |
| 380 |
JOINT DESTRUCTION |
158 |
| 381 |
PARAESTHESIA ORAL |
157 |
| 382 |
CYTOMEGALOVIRUS VIRAEMIA |
155 |
| 383 |
DEPRESSED MOOD |
153 |
| 384 |
NEUTROPHIL COUNT DECREASED |
153 |
| 385 |
MUSCULOSKELETAL DISCOMFORT |
152 |
| 386 |
PLASMA CELL MYELOMA |
152 |
| 387 |
IMMUNE THROMBOCYTOPENIA |
151 |
| 388 |
RIB FRACTURE |
151 |
| 389 |
STOMATITIS |
151 |
| 390 |
RESPIRATORY TRACT CONGESTION |
150 |
| 391 |
DYSARTHRIA |
148 |
| 392 |
HAEMATOMA |
148 |
| 393 |
NERVOUSNESS |
148 |
| 394 |
DRUG RESISTANCE |
147 |
| 395 |
OSTEOARTHRITIS |
146 |
| 396 |
PROCEDURAL PAIN |
145 |
| 397 |
SKIN LESION |
144 |
| 398 |
HEPATOTOXICITY |
143 |
| 399 |
INJECTION SITE EXTRAVASATION |
142 |
| 400 |
TRANSPLANT REJECTION |
142 |
| 401 |
APHASIA |
141 |
| 402 |
BLOOD IRON DECREASED |
141 |
| 403 |
BREAST CANCER |
141 |
| 404 |
BRONCHOSPASM |
141 |
| 405 |
HYPONATRAEMIA |
141 |
| 406 |
STREPTOCOCCAL INFECTION |
141 |
| 407 |
DYSPNOEA EXERTIONAL |
140 |
| 408 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
140 |
| 409 |
BLOOD IMMUNOGLOBULIN G INCREASED |
139 |
| 410 |
EPSTEIN-BARR VIRUS INFECTION |
139 |
| 411 |
IRRITABILITY |
139 |
| 412 |
LARYNGITIS |
139 |
| 413 |
OSTEOMYELITIS |
139 |
| 414 |
SNEEZING |
139 |
| 415 |
SKIN CANCER |
138 |
| 416 |
ARRHYTHMIA |
137 |
| 417 |
INFUSION SITE SCAR |
137 |
| 418 |
WHEELCHAIR USER |
137 |
| 419 |
RASH PAPULAR |
135 |
| 420 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
135 |
| 421 |
DYSURIA |
134 |
| 422 |
NEPHROPATHY TOXIC |
134 |
| 423 |
SKIN REACTION |
134 |
| 424 |
SPINAL FRACTURE |
134 |
| 425 |
CYTOKINE RELEASE SYNDROME |
133 |
| 426 |
MENTAL DISORDER |
133 |
| 427 |
ANTIBODY TEST POSITIVE |
132 |
| 428 |
DRUG DOSE OMISSION |
132 |
| 429 |
DRUG TOLERANCE |
132 |
| 430 |
EYE SWELLING |
131 |
| 431 |
OBSTRUCTION |
131 |
| 432 |
PHARYNGEAL SWELLING |
131 |
| 433 |
AMNESIA |
130 |
| 434 |
CHROMATURIA |
130 |
| 435 |
ESCHERICHIA INFECTION |
130 |
| 436 |
POLLAKIURIA |
130 |
| 437 |
JOINT STIFFNESS |
129 |
| 438 |
PRODUCT ADMINISTRATION ERROR |
129 |
| 439 |
SPLENOMEGALY |
129 |
| 440 |
HERNIA |
128 |
| 441 |
INJECTION SITE RASH |
128 |
| 442 |
INJECTION SITE URTICARIA |
128 |
| 443 |
MASS |
128 |
| 444 |
ASPERGILLUS INFECTION |
127 |
| 445 |
COLD SWEAT |
127 |
| 446 |
SKIN DISORDER |
127 |
| 447 |
ARTHROPOD BITE |
126 |
| 448 |
BLOOD POTASSIUM DECREASED |
126 |
| 449 |
COGNITIVE DISORDER |
126 |
| 450 |
DRY EYE |
126 |
| 451 |
RHINITIS |
126 |
| 452 |
CORONARY ARTERY DISEASE |
125 |
| 453 |
DISEASE RECURRENCE |
125 |
| 454 |
INTESTINAL OBSTRUCTION |
125 |
| 455 |
ADVERSE EVENT |
124 |
| 456 |
BACTERAEMIA |
124 |
| 457 |
FOOD ALLERGY |
124 |
| 458 |
TOOTH ABSCESS |
124 |
| 459 |
HEPATIC FUNCTION ABNORMAL |
123 |
| 460 |
PERICARDIAL EFFUSION |
123 |
| 461 |
BACK DISORDER |
122 |
| 462 |
FLANK PAIN |
122 |
| 463 |
LIVER FUNCTION TEST ABNORMAL |
122 |
| 464 |
PULMONARY MASS |
122 |
| 465 |
ADMINISTRATION SITE SWELLING |
121 |
| 466 |
HAEMATOCHEZIA |
121 |
| 467 |
POOR QUALITY SLEEP |
121 |
| 468 |
PREMATURE DELIVERY |
121 |
| 469 |
FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION |
120 |
| 470 |
HEPATITIS B CORE ANTIBODY POSITIVE |
120 |
| 471 |
POST PROCEDURAL INFECTION |
120 |
| 472 |
RASH GENERALISED |
120 |
| 473 |
BLOOD PRESSURE SYSTOLIC INCREASED |
119 |
| 474 |
BONE DENSITY DECREASED |
119 |
| 475 |
C-REACTIVE PROTEIN ABNORMAL |
119 |
| 476 |
IRRITABLE BOWEL SYNDROME |
119 |
| 477 |
UPPER LIMB FRACTURE |
119 |
| 478 |
ANAPHYLACTOID REACTION |
118 |
| 479 |
EPILEPSY |
118 |
| 480 |
NIGHT SWEATS |
118 |
| 481 |
INJECTION SITE INDURATION |
117 |
| 482 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
116 |
| 483 |
LYMPHOPENIA |
116 |
| 484 |
ORAL HERPES |
116 |
| 485 |
SHOCK |
116 |
| 486 |
DISTURBANCE IN ATTENTION |
115 |
| 487 |
IMPAIRED HEALING |
115 |
| 488 |
ORAL CANDIDIASIS |
115 |
| 489 |
RASH MACULO-PAPULAR |
115 |
| 490 |
OBSTRUCTIVE AIRWAYS DISORDER |
114 |
| 491 |
RHINOVIRUS INFECTION |
113 |
| 492 |
SKIN IRRITATION |
112 |
| 493 |
SKIN ULCER |
112 |
| 494 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
111 |
| 495 |
ENCEPHALITIS |
111 |
| 496 |
NO THERAPEUTIC RESPONSE |
111 |
| 497 |
INFUSION SITE DISCOLOURATION |
110 |
| 498 |
INFUSION SITE OEDEMA |
110 |
| 499 |
PETECHIAE |
110 |
| 500 |
PRODUCT DOSE OMISSION |
110 |
| 501 |
PRODUCT PRESCRIBING ISSUE |
110 |
| 502 |
RESTLESSNESS |
110 |
| 503 |
HAEMOPTYSIS |
109 |
| 504 |
OVERDOSE |
109 |
| 505 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
109 |
| 506 |
RHEUMATOID FACTOR POSITIVE |
109 |
| 507 |
THERAPY PARTIAL RESPONDER |
109 |
| 508 |
ACUTE RESPIRATORY FAILURE |
108 |
| 509 |
BK VIRUS INFECTION |
108 |
| 510 |
DEVICE RELATED INFECTION |
108 |
| 511 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
108 |
| 512 |
NERVOUS SYSTEM DISORDER |
108 |
| 513 |
TOXIC EPIDERMAL NECROLYSIS |
108 |
| 514 |
BLOOD SODIUM DECREASED |
107 |
| 515 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
107 |
| 516 |
COAGULOPATHY |
106 |
| 517 |
LIGAMENT SPRAIN |
106 |
| 518 |
ADMINISTRATION SITE PAIN |
105 |
| 519 |
BLOOD PRESSURE FLUCTUATION |
105 |
| 520 |
CEREBRAL HAEMORRHAGE |
105 |
| 521 |
JUVENILE IDIOPATHIC ARTHRITIS |
105 |
| 522 |
LYME DISEASE |
105 |
| 523 |
MOVEMENT DISORDER |
105 |
| 524 |
SCIATICA |
105 |
| 525 |
SPUTUM DISCOLOURED |
105 |
| 526 |
THROMBOTIC MICROANGIOPATHY |
105 |
| 527 |
CROHN^S DISEASE |
104 |
| 528 |
DEVICE LEAKAGE |
104 |
| 529 |
FLATULENCE |
104 |
| 530 |
FOETAL GROWTH RESTRICTION |
104 |
| 531 |
FOOT DEFORMITY |
104 |
| 532 |
HEREDITARY ANGIOEDEMA |
104 |
| 533 |
IMPAIRED GASTRIC EMPTYING |
104 |
| 534 |
THYROID DISORDER |
104 |
| 535 |
BLOOD IMMUNOGLOBULIN A DECREASED |
103 |
| 536 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
103 |
| 537 |
DISORIENTATION |
103 |
| 538 |
IMMUNE SYSTEM DISORDER |
103 |
| 539 |
CYTOPENIA |
102 |
| 540 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
102 |
| 541 |
URINARY RETENTION |
102 |
| 542 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
101 |
| 543 |
ADVERSE REACTION |
101 |
| 544 |
BLOOD BILIRUBIN INCREASED |
101 |
| 545 |
BLOOD URINE PRESENT |
101 |
| 546 |
CONCUSSION |
101 |
| 547 |
ENCEPHALOPATHY |
101 |
| 548 |
FOOD POISONING |
101 |
| 549 |
HEPATIC FAILURE |
101 |
| 550 |
HEPATITIS B |
101 |
| 551 |
INJECTION SITE DISCHARGE |
101 |
| 552 |
PULMONARY THROMBOSIS |
101 |
| 553 |
THERAPEUTIC RESPONSE SHORTENED |
101 |
| 554 |
MUSCLE TWITCHING |
100 |
| 555 |
MUSCULOSKELETAL CHEST PAIN |
100 |
| 556 |
TRANSFUSION REACTION |
100 |
| 557 |
EYE IRRITATION |
99 |
| 558 |
GASTRITIS |
99 |
| 559 |
JAUNDICE |
99 |
| 560 |
LOWER LIMB FRACTURE |
99 |
| 561 |
PEMPHIGUS |
99 |
| 562 |
CYSTITIS HAEMORRHAGIC |
98 |
| 563 |
LEUKAEMIA |
98 |
| 564 |
WOUND INFECTION |
98 |
| 565 |
EYE DISORDER |
97 |
| 566 |
FEAR OF INJECTION |
97 |
| 567 |
INTENTIONAL DOSE OMISSION |
97 |
| 568 |
OCULAR HYPERAEMIA |
97 |
| 569 |
SARS-COV-2 TEST POSITIVE |
97 |
| 570 |
SUSPECTED OFF LABEL USE |
97 |
| 571 |
GLOSSODYNIA |
96 |
| 572 |
HYPOAESTHESIA ORAL |
96 |
| 573 |
PNEUMOTHORAX |
96 |
| 574 |
VASCULITIS |
96 |
| 575 |
CONVULSION |
95 |
| 576 |
DEVICE BREAKAGE |
95 |
| 577 |
SJOGREN^S SYNDROME |
95 |
| 578 |
UNRESPONSIVE TO STIMULI |
95 |
| 579 |
INJURY |
94 |
| 580 |
PULMONARY TOXICITY |
94 |
| 581 |
RED BLOOD CELL COUNT DECREASED |
94 |
| 582 |
ACUTE MYOCARDIAL INFARCTION |
93 |
| 583 |
CRYING |
93 |
| 584 |
GASTRIC ULCER |
93 |
| 585 |
HAND DEFORMITY |
93 |
| 586 |
INJECTION SITE DISCOMFORT |
93 |
| 587 |
PRURITUS GENERALISED |
93 |
| 588 |
BLOOD GLUCOSE DECREASED |
92 |
| 589 |
DISSEMINATED INTRAVASCULAR COAGULATION |
92 |
| 590 |
PAIN IN JAW |
92 |
| 591 |
VASCULAR DEVICE INFECTION |
92 |
| 592 |
APHONIA |
91 |
| 593 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
91 |
| 594 |
COOMBS DIRECT TEST POSITIVE |
91 |
| 595 |
GUILLAIN-BARRE SYNDROME |
91 |
| 596 |
HYPERVOLAEMIA |
91 |
| 597 |
PANIC ATTACK |
91 |
| 598 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
90 |
| 599 |
DYSSTASIA |
90 |
| 600 |
GASTROINTESTINAL TOXICITY |
90 |
| 601 |
INJECTION SITE WARMTH |
90 |
| 602 |
POSTOPERATIVE WOUND INFECTION |
90 |
| 603 |
SLEEP APNOEA SYNDROME |
90 |
| 604 |
TOOTH DISORDER |
90 |
| 605 |
TOXICITY TO VARIOUS AGENTS |
90 |
| 606 |
UPPER-AIRWAY COUGH SYNDROME |
90 |
| 607 |
URINARY INCONTINENCE |
90 |
| 608 |
PRODUCT LEAKAGE |
89 |
| 609 |
HYPOACUSIS |
88 |
| 610 |
KNEE ARTHROPLASTY |
88 |
| 611 |
PHOTOSENSITIVITY REACTION |
88 |
| 612 |
POST-ACUTE COVID-19 SYNDROME |
88 |
| 613 |
PSORIATIC ARTHROPATHY |
88 |
| 614 |
RENAL FAILURE ACUTE |
88 |
| 615 |
THERAPEUTIC RESPONSE DECREASED |
88 |
| 616 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
88 |
| 617 |
ADMINISTRATION SITE ERYTHEMA |
87 |
| 618 |
ANKLE FRACTURE |
87 |
| 619 |
BODY TEMPERATURE DECREASED |
87 |
| 620 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
87 |
| 621 |
HEPATITIS B SURFACE ANTIBODY POSITIVE |
87 |
| 622 |
INFUSION SITE VESICLES |
87 |
| 623 |
MENTAL IMPAIRMENT |
87 |
| 624 |
RECTAL HAEMORRHAGE |
87 |
| 625 |
SPINAL PAIN |
87 |
| 626 |
WRIST FRACTURE |
87 |
| 627 |
BEDRIDDEN |
86 |
| 628 |
BRONCHOPULMONARY ASPERGILLOSIS |
86 |
| 629 |
INFUSION SITE INFECTION |
86 |
| 630 |
SPINAL OPERATION |
86 |
| 631 |
BODY HEIGHT BELOW NORMAL |
85 |
| 632 |
GOUT |
85 |
| 633 |
HEMIPARESIS |
85 |
| 634 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
85 |
| 635 |
PERIPHERAL COLDNESS |
85 |
| 636 |
VEIN DISORDER |
85 |
| 637 |
ABSCESS |
84 |
| 638 |
GASTROENTERITIS |
84 |
| 639 |
MEDICATION ERROR |
84 |
| 640 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
84 |
| 641 |
ROTATOR CUFF SYNDROME |
84 |
| 642 |
CYST |
83 |
| 643 |
EYELID PTOSIS |
83 |
| 644 |
HYPERGLYCAEMIA |
83 |
| 645 |
INTERVERTEBRAL DISC PROTRUSION |
83 |
| 646 |
PULMONARY HYPERTENSION |
83 |
| 647 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
82 |
| 648 |
CHOLELITHIASIS |
82 |
| 649 |
MULTIPLE SCLEROSIS |
82 |
| 650 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
82 |
| 651 |
SECRETION DISCHARGE |
82 |
| 652 |
ASPIRATION |
81 |
| 653 |
DELIRIUM |
81 |
| 654 |
HEPATITIS |
81 |
| 655 |
THERAPEUTIC RESPONSE UNEXPECTED |
81 |
| 656 |
TOOTHACHE |
81 |
| 657 |
BLOOD TEST ABNORMAL |
80 |
| 658 |
DERMATOMYOSITIS |
80 |
| 659 |
BACK INJURY |
79 |
| 660 |
BLOOD IMMUNOGLOBULIN M DECREASED |
79 |
| 661 |
FULL BLOOD COUNT ABNORMAL |
79 |
| 662 |
IMPAIRED WORK ABILITY |
79 |
| 663 |
INJECTION SITE IRRITATION |
79 |
| 664 |
INSPIRATORY CAPACITY DECREASED |
79 |
| 665 |
LABORATORY TEST ABNORMAL |
79 |
| 666 |
RENAL PAIN |
79 |
| 667 |
RESPIRATORY TRACT INFECTION VIRAL |
79 |
| 668 |
RESTLESS LEGS SYNDROME |
79 |
| 669 |
ATAXIA |
78 |
| 670 |
BRAIN OEDEMA |
78 |
| 671 |
HELICOBACTER INFECTION |
78 |
| 672 |
LYMPHOCYTE COUNT DECREASED |
78 |
| 673 |
PARANASAL SINUS DISCOMFORT |
78 |
| 674 |
PNEUMONIA FUNGAL |
78 |
| 675 |
WALKING AID USER |
78 |
| 676 |
AGRANULOCYTOSIS |
77 |
| 677 |
BLADDER DISORDER |
77 |
| 678 |
CIRCULATORY COLLAPSE |
77 |
| 679 |
COLITIS ULCERATIVE |
77 |
| 680 |
DYSGEUSIA |
77 |
| 681 |
ENCEPHALITIS CYTOMEGALOVIRUS |
77 |
| 682 |
HEPATOMEGALY |
77 |
| 683 |
MENTAL STATUS CHANGES |
77 |
| 684 |
DEMENTIA |
76 |
| 685 |
DERMATITIS |
76 |
| 686 |
FACIAL PAIN |
76 |
| 687 |
HYPERTHERMIA |
76 |
| 688 |
INJECTION SITE NODULE |
76 |
| 689 |
LUNG NEOPLASM MALIGNANT |
76 |
| 690 |
ULCER |
76 |
| 691 |
DRUG EFFECT DECREASED |
75 |
| 692 |
EYE PRURITUS |
75 |
| 693 |
LIVER FUNCTION TEST INCREASED |
75 |
| 694 |
NOROVIRUS INFECTION |
75 |
| 695 |
SENSITIVE SKIN |
75 |
| 696 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
75 |
| 697 |
CARPAL TUNNEL SYNDROME |
74 |
| 698 |
EATING DISORDER |
74 |
| 699 |
FEEDING DISORDER |
74 |
| 700 |
GRAFT VERSUS HOST DISEASE |
74 |
| 701 |
JOINT EFFUSION |
74 |
| 702 |
LACRIMATION INCREASED |
74 |
| 703 |
MYOSITIS |
74 |
| 704 |
ATYPICAL PNEUMONIA |
73 |
| 705 |
DEAFNESS |
73 |
| 706 |
HYPOGLYCAEMIA |
73 |
| 707 |
MUSCLE STRAIN |
73 |
| 708 |
MUSCLE TIGHTNESS |
73 |
| 709 |
OROPHARYNGEAL DISCOMFORT |
73 |
| 710 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
73 |
| 711 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
73 |
| 712 |
SKIN ABRASION |
73 |
| 713 |
TASTE DISORDER |
73 |
| 714 |
UROSEPSIS |
73 |
| 715 |
AUTOIMMUNE THYROIDITIS |
72 |
| 716 |
BLOOD MAGNESIUM DECREASED |
72 |
| 717 |
GALLBLADDER DISORDER |
72 |
| 718 |
HYPOPHAGIA |
72 |
| 719 |
DRUG EXPOSURE DURING PREGNANCY |
71 |
| 720 |
HAEMATOLOGICAL INFECTION |
71 |
| 721 |
HALLUCINATION |
71 |
| 722 |
IMMUNE-MEDIATED MYOSITIS |
71 |
| 723 |
MOUTH ULCERATION |
71 |
| 724 |
SKIN BURNING SENSATION |
71 |
| 725 |
STATUS EPILEPTICUS |
71 |
| 726 |
DERMATITIS ALLERGIC |
70 |
| 727 |
DEVICE OCCLUSION |
70 |
| 728 |
DRUG ERUPTION |
70 |
| 729 |
DYSKINESIA |
70 |
| 730 |
FOETAL DEATH |
70 |
| 731 |
MALIGNANT NEOPLASM PROGRESSION |
70 |
| 732 |
METABOLIC ACIDOSIS |
70 |
| 733 |
ORAL INFECTION |
70 |
| 734 |
ORAL PAIN |
70 |
| 735 |
SECONDARY IMMUNODEFICIENCY |
70 |
| 736 |
BODY HEIGHT DECREASED |
69 |
| 737 |
CHRONIC KIDNEY DISEASE |
69 |
| 738 |
DEVICE DIFFICULT TO USE |
69 |
| 739 |
FINE MOTOR SKILL DYSFUNCTION |
69 |
| 740 |
GASTRIC INFECTION |
69 |
| 741 |
HAEMORRHAGE INTRACRANIAL |
69 |
| 742 |
HEART RATE IRREGULAR |
69 |
| 743 |
HYPOALBUMINAEMIA |
69 |
| 744 |
LIVEDO RETICULARIS |
69 |
| 745 |
PULMONARY CONGESTION |
69 |
| 746 |
QUALITY OF LIFE DECREASED |
69 |
| 747 |
SKIN MASS |
69 |
| 748 |
SUSPECTED COVID-19 |
69 |
| 749 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
68 |
| 750 |
EPSTEIN-BARR VIRAEMIA |
68 |
| 751 |
FOOT OPERATION |
68 |
| 752 |
IMMUNOSUPPRESSION |
68 |
| 753 |
SUICIDAL IDEATION |
68 |
| 754 |
EMOTIONAL DISTRESS |
67 |
| 755 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
67 |
| 756 |
HEPATIC CIRRHOSIS |
67 |
| 757 |
ISCHAEMIC STROKE |
67 |
| 758 |
LYMPHADENITIS |
67 |
| 759 |
PNEUMONITIS |
67 |
| 760 |
TRANSAMINASES INCREASED |
67 |
| 761 |
DEVICE MALFUNCTION |
66 |
| 762 |
HYPERTENSIVE CRISIS |
66 |
| 763 |
IMMUNISATION REACTION |
66 |
| 764 |
PRODUCT SUBSTITUTION ISSUE |
66 |
| 765 |
SCAB |
66 |
| 766 |
BASAL CELL CARCINOMA |
65 |
| 767 |
BLOOD PRESSURE SYSTOLIC DECREASED |
65 |
| 768 |
COMPLICATION ASSOCIATED WITH DEVICE |
65 |
| 769 |
GENERALISED TONIC-CLONIC SEIZURE |
65 |
| 770 |
HAND FRACTURE |
65 |
| 771 |
HYPOTHYROIDISM |
65 |
| 772 |
IMPAIRED QUALITY OF LIFE |
65 |
| 773 |
LEUKOCYTOSIS |
65 |
| 774 |
NERVE COMPRESSION |
65 |
| 775 |
PERICARDITIS |
65 |
| 776 |
PHARYNGEAL OEDEMA |
65 |
| 777 |
POLYNEUROPATHY |
65 |
| 778 |
RHESUS ANTIBODIES POSITIVE |
65 |
| 779 |
ACUTE PULMONARY OEDEMA |
64 |
| 780 |
ALLERGY TO IMMUNOGLOBULIN THERAPY |
64 |
| 781 |
BURSITIS |
64 |
| 782 |
FEELING JITTERY |
64 |
| 783 |
HEPATIC STEATOSIS |
64 |
| 784 |
MYASTHENIA GRAVIS CRISIS |
64 |
| 785 |
OSTEONECROSIS |
64 |
| 786 |
REBOUND EFFECT |
64 |
| 787 |
SINUSITIS BACTERIAL |
64 |
| 788 |
TYPE 2 DIABETES MELLITUS |
64 |
| 789 |
ADENOVIRUS INFECTION |
63 |
| 790 |
FEMUR FRACTURE |
63 |
| 791 |
INJECTION SITE OEDEMA |
63 |
| 792 |
LIVER INJURY |
63 |
| 793 |
MULTIPLE-DRUG RESISTANCE |
63 |
| 794 |
PARALYSIS |
63 |
| 795 |
PLEURISY |
63 |
| 796 |
VEIN RUPTURE |
63 |
| 797 |
ADMINISTRATION SITE EXTRAVASATION |
62 |
| 798 |
CARDIOGENIC SHOCK |
62 |
| 799 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
62 |
| 800 |
DRUG-INDUCED LIVER INJURY |
62 |
| 801 |
ELECTROLYTE IMBALANCE |
62 |
| 802 |
BLOOD CHOLESTEROL INCREASED |
61 |
| 803 |
CHOKING |
61 |
| 804 |
ENTEROCOCCAL INFECTION |
61 |
| 805 |
INFUSION SITE INFLAMMATION |
61 |
| 806 |
MAST CELL ACTIVATION SYNDROME |
61 |
| 807 |
PRESCRIBED UNDERDOSE |
61 |
| 808 |
BLOOD PRESSURE DIASTOLIC DECREASED |
60 |
| 809 |
CEREBRAL INFARCTION |
60 |
| 810 |
GASTRIC DISORDER |
60 |
| 811 |
GLOMERULAR FILTRATION RATE DECREASED |
60 |
| 812 |
MALABSORPTION FROM INJECTION SITE |
60 |
| 813 |
MULTI-ORGAN FAILURE |
60 |
| 814 |
PLATELET COUNT INCREASED |
60 |
| 815 |
TREATMENT DELAYED |
60 |
| 816 |
DRY THROAT |
59 |
| 817 |
FRUSTRATION TOLERANCE DECREASED |
59 |
| 818 |
HORDEOLUM |
59 |
| 819 |
NERVE INJURY |
59 |
| 820 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
59 |
| 821 |
ACNE |
58 |
| 822 |
ACUTE HEPATIC FAILURE |
58 |
| 823 |
HAEMATOCRIT DECREASED |
58 |
| 824 |
HIATUS HERNIA |
58 |
| 825 |
PARTIAL SEIZURES |
58 |
| 826 |
SERUM FERRITIN INCREASED |
58 |
| 827 |
TOOTH FRACTURE |
58 |
| 828 |
ABDOMINAL PAIN LOWER |
57 |
| 829 |
AGGRESSION |
57 |
| 830 |
ANTINUCLEAR ANTIBODY POSITIVE |
57 |
| 831 |
ARTHRITIS INFECTIVE |
57 |
| 832 |
DECREASED IMMUNE RESPONSIVENESS |
57 |
| 833 |
DRUG EFFECT LESS THAN EXPECTED |
57 |
| 834 |
FULL BLOOD COUNT DECREASED |
57 |
| 835 |
GLAUCOMA |
57 |
| 836 |
GRIP STRENGTH DECREASED |
57 |
| 837 |
PNEUMONIA VIRAL |
57 |
| 838 |
ACCIDENT |
56 |
| 839 |
ACCIDENTAL EXPOSURE TO PRODUCT |
56 |
| 840 |
ANGINA PECTORIS |
56 |
| 841 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
56 |
| 842 |
HYPERKALAEMIA |
56 |
| 843 |
IMMUNODEFICIENCY COMMON VARIABLE |
56 |
| 844 |
INJECTION SITE INFECTION |
56 |
| 845 |
MISLEADING LABORATORY TEST RESULT |
56 |
| 846 |
PNEUMONIA PSEUDOMONAL |
56 |
| 847 |
RETCHING |
56 |
| 848 |
SPUTUM PURULENT |
56 |
| 849 |
TOXIC SKIN ERUPTION |
56 |
| 850 |
DISABILITY |
55 |
| 851 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
55 |
| 852 |
FACIAL PARALYSIS |
55 |
| 853 |
PERONEAL NERVE PALSY |
55 |
| 854 |
RALES |
55 |
| 855 |
RASH VESICULAR |
55 |
| 856 |
SERUM SICKNESS |
55 |
| 857 |
STIFF PERSON SYNDROME |
55 |
| 858 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
55 |
| 859 |
ADMINISTRATION SITE REACTION |
54 |
| 860 |
BLOOD IMMUNOGLOBULIN G ABNORMAL |
54 |
| 861 |
BLOOD LACTIC ACID INCREASED |
54 |
| 862 |
COVID-19 IMMUNISATION |
54 |
| 863 |
ELECTRIC SHOCK SENSATION |
54 |
| 864 |
FOLLICULITIS |
54 |
| 865 |
JOINT DISLOCATION |
54 |
| 866 |
KLEBSIELLA INFECTION |
54 |
| 867 |
PNEUMONIA CYTOMEGALOVIRAL |
54 |
| 868 |
STEVENS-JOHNSON SYNDROME |
54 |
| 869 |
EAR DISCOMFORT |
53 |
| 870 |
ENCEPHALITIS AUTOIMMUNE |
53 |
| 871 |
HEART RATE ABNORMAL |
53 |
| 872 |
INFECTIOUS MONONUCLEOSIS |
53 |
| 873 |
NEOPLASM |
53 |
| 874 |
SENSORY DISTURBANCE |
53 |
| 875 |
SPINAL DISORDER |
53 |
| 876 |
ANIMAL BITE |
52 |
| 877 |
EOSINOPHILIA |
52 |
| 878 |
INTERNAL HAEMORRHAGE |
52 |
| 879 |
LYMPHOEDEMA |
52 |
| 880 |
MUCOSAL INFLAMMATION |
52 |
| 881 |
SINUS HEADACHE |
52 |
| 882 |
SKIN FISSURES |
52 |
| 883 |
SLUGGISHNESS |
52 |
| 884 |
APPENDICITIS |
51 |
| 885 |
ATELECTASIS |
51 |
| 886 |
CARDIOVASCULAR DISORDER |
51 |
| 887 |
CREPITATIONS |
51 |
| 888 |
FREQUENT BOWEL MOVEMENTS |
51 |
| 889 |
INCREASED TENDENCY TO BRUISE |
51 |
| 890 |
INTENTIONAL PRODUCT MISUSE |
51 |
| 891 |
PELVIC FRACTURE |
51 |
| 892 |
PRODUCT ADMINISTRATION INTERRUPTED |
51 |
| 893 |
PURPURA |
51 |
| 894 |
VENTRICULAR TACHYCARDIA |
51 |
| 895 |
BLINDNESS UNILATERAL |
50 |
| 896 |
BLOOD GLUCOSE ABNORMAL |
50 |
| 897 |
BRAIN INJURY |
50 |
| 898 |
FACE OEDEMA |
50 |
| 899 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
50 |
| 900 |
HAEMORRHOIDS |
50 |
| 901 |
HYPERAESTHESIA |
50 |
| 902 |
MYELODYSPLASTIC SYNDROME |
50 |
| 903 |
PAPULE |
50 |
| 904 |
PHLEBITIS |
50 |
| 905 |
RESPIRATORY ARREST |
50 |
| 906 |
TRANSFUSION-RELATED CIRCULATORY OVERLOAD |
50 |
| 907 |
CENTRAL NERVOUS SYSTEM LESION |
49 |
| 908 |
ENERGY INCREASED |
49 |
| 909 |
EXPIRED PRODUCT ADMINISTERED |
49 |
| 910 |
FUNGAL SKIN INFECTION |
49 |
| 911 |
GASTROINTESTINAL PAIN |
49 |
| 912 |
HYPOTHERMIA |
49 |
| 913 |
KIDNEY TRANSPLANT REJECTION |
49 |
| 914 |
MENINGITIS VIRAL |
49 |
| 915 |
MOTOR DYSFUNCTION |
49 |
| 916 |
MOUTH SWELLING |
49 |
| 917 |
OXYGEN SATURATION ABNORMAL |
49 |
| 918 |
PRODUCT PRESCRIBING ERROR |
49 |
| 919 |
PYELONEPHRITIS |
49 |
| 920 |
SKIN WARM |
49 |
| 921 |
SQUAMOUS CELL CARCINOMA |
49 |
| 922 |
ANGER |
48 |
| 923 |
BODY TEMPERATURE ABNORMAL |
48 |
| 924 |
CARDIOMYOPATHY |
48 |
| 925 |
GINGIVAL BLEEDING |
48 |
| 926 |
HEPATOCELLULAR INJURY |
48 |
| 927 |
HIP ARTHROPLASTY |
48 |
| 928 |
INTRACRANIAL PRESSURE INCREASED |
48 |
| 929 |
MYOCARDITIS |
48 |
| 930 |
PLATELET COUNT ABNORMAL |
48 |
| 931 |
SINUS OPERATION |
48 |
| 932 |
TENDONITIS |
48 |
| 933 |
THERMAL BURN |
48 |
| 934 |
ACUTE MYELOID LEUKAEMIA |
47 |
| 935 |
CLOSTRIDIUM DIFFICILE COLITIS |
47 |
| 936 |
EAR DISORDER |
47 |
| 937 |
FAECES DISCOLOURED |
47 |
| 938 |
MENISCUS INJURY |
47 |
| 939 |
PRESCRIBED OVERDOSE |
47 |
| 940 |
PRODUCT PHYSICAL ISSUE |
47 |
| 941 |
PROSTATE CANCER |
47 |
| 942 |
CAESAREAN SECTION |
46 |
| 943 |
CHOLECYSTECTOMY |
46 |
| 944 |
DRUG SPECIFIC ANTIBODY |
46 |
| 945 |
IMMUNOGLOBULINS ABNORMAL |
46 |
| 946 |
INFUSION SITE HAEMATOMA |
46 |
| 947 |
INJECTION SITE SCAR |
46 |
| 948 |
INJURY ASSOCIATED WITH DEVICE |
46 |
| 949 |
LOCAL REACTION |
46 |
| 950 |
MALIGNANT MELANOMA |
46 |
| 951 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
46 |
| 952 |
PRODUCT PREPARATION ISSUE |
46 |
| 953 |
TROPONIN INCREASED |
46 |
| 954 |
ANKLE ARTHROPLASTY |
45 |
| 955 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
45 |
| 956 |
BLOOD UREA INCREASED |
45 |
| 957 |
COLON CANCER |
45 |
| 958 |
DERMATITIS EXFOLIATIVE GENERALISED |
45 |
| 959 |
DRUG DEPENDENCE |
45 |
| 960 |
EMBOLISM |
45 |
| 961 |
EMOTIONAL DISORDER |
45 |
| 962 |
INFECTED BITE |
45 |
| 963 |
MYASTHENIC SYNDROME |
45 |
| 964 |
NEOPLASM PROGRESSION |
45 |
| 965 |
NON-HODGKIN^S LYMPHOMA |
45 |
| 966 |
SMALL INTESTINAL OBSTRUCTION |
45 |
| 967 |
STAPHYLOCOCCAL BACTERAEMIA |
45 |
| 968 |
SUPRAVENTRICULAR TACHYCARDIA |
45 |
| 969 |
THIRST |
45 |
| 970 |
ELECTROCARDIOGRAM QT PROLONGED |
44 |
| 971 |
FEELING OF BODY TEMPERATURE CHANGE |
44 |
| 972 |
GINGIVITIS |
44 |
| 973 |
HYPERBILIRUBINAEMIA |
44 |
| 974 |
LOW BIRTH WEIGHT BABY |
44 |
| 975 |
LUNG INFILTRATION |
44 |
| 976 |
MELAENA |
44 |
| 977 |
OTITIS MEDIA |
44 |
| 978 |
PARANASAL SINUS HYPERSECRETION |
44 |
| 979 |
POLYP |
44 |
| 980 |
VARICELLA ZOSTER VIRUS INFECTION |
44 |
| 981 |
ANTI A ANTIBODY POSITIVE |
43 |
| 982 |
BONE MARROW FAILURE |
43 |
| 983 |
ERUCTATION |
43 |
| 984 |
GESTATIONAL DIABETES |
43 |
| 985 |
HERPES SIMPLEX |
43 |
| 986 |
HYPERTRANSAMINASAEMIA |
43 |
| 987 |
MENINGISM |
43 |
| 988 |
PRODUCT CONTAINER ISSUE |
43 |
| 989 |
AGEUSIA |
42 |
| 990 |
ANAL INCONTINENCE |
42 |
| 991 |
ATRIAL FLUTTER |
42 |
| 992 |
CROUP INFECTIOUS |
42 |
| 993 |
CUSHINGOID |
42 |
| 994 |
DERMATITIS BULLOUS |
42 |
| 995 |
HEPATITIS C |
42 |
| 996 |
HYPOKINESIA |
42 |
| 997 |
IMMUNOGLOBULINS INCREASED |
42 |
| 998 |
INJECTION SITE DISCOLOURATION |
42 |
| 999 |
INJECTION SITE VESICLES |
42 |